Details for New Drug Application (NDA): 063067
✉ Email this page to a colleague
NDA 063067 describes DYNACIN, which is a drug marketed by Alvogen and is included in one NDA. Additional details are available on the DYNACIN profile page.
The generic ingredient in DYNACIN is minocycline hydrochloride. There are fifteen drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the minocycline hydrochloride profile page.
The generic ingredient in DYNACIN is minocycline hydrochloride. There are fifteen drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the minocycline hydrochloride profile page.
Summary for 063067
| Tradename: | DYNACIN |
| Applicant: | Alvogen |
| Ingredient: | minocycline hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 063067
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 100MG BASE | ||||
| Approval Date: | Jul 31, 1990 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 75MG BASE | ||||
| Approval Date: | Sep 15, 1999 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 50MG BASE | ||||
| Approval Date: | Aug 14, 1990 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
